Patents Assigned to Torquin, LLC
  • Use of targeted oxidative therapeutic formulation in bone regeneration
    Patent number: 7572782
    Abstract: A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide (“DMSO”); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively stimulate bone regeneration and increase osteoblastic activity in a patient.
    Type: Grant
    Filed: May 10, 2005
    Date of Patent: August 11, 2009
    Assignee: Torquin, LLC
    Inventor: Robert F. Hofmann
  • Targeted oxidative therapeutic formulation
    Patent number: 7521440
    Abstract: Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to treat horses infected with Sarcocystis protozoal infections.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: April 21, 2009
    Assignee: Torquin, LLC
    Inventor: Robert F. Hofmann